切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2026, Vol. 20 ›› Issue (01) : 59 -62. doi: 10.3877/cma.j.issn.1674-3946.2026.01.017

论著

脾静脉近端结扎在腹腔镜脾切除术后预防门静脉血栓形成的疗效分析
吴鹏, 许维(), 郑世海, 宋劲松   
  1. 413700 湖北天门,湖北省天门市第一人民医院普外一区
  • 收稿日期:2025-02-15 出版日期:2026-02-26
  • 通信作者: 许维

Efficacy analysis of proximal splenic vein ligation in preventing portal vein thrombosis after laparoscopic splenectomy

Peng Wu, Wei Xu(), Shihai Zheng, Jinsong Song   

  1. Department of General Surgery, The First People’s Hospital of Tianmen City, Tianmen Hubei Province 413700, China
  • Received:2025-02-15 Published:2026-02-26
  • Corresponding author: Wei Xu
引用本文:

吴鹏, 许维, 郑世海, 宋劲松. 脾静脉近端结扎在腹腔镜脾切除术后预防门静脉血栓形成的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 59-62.

Peng Wu, Wei Xu, Shihai Zheng, Jinsong Song. Efficacy analysis of proximal splenic vein ligation in preventing portal vein thrombosis after laparoscopic splenectomy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(01): 59-62.

目的

探讨腹腔镜脾切除术中行脾静脉近端结扎对术后门静脉血栓形成的预防效果。

方法

回顾性分析2022年1月至2025年1月行手术治疗的58例门静脉高压症患者临床资料,按术中是否行脾静脉近端结扎分为A组(n=22,术中结扎脾静脉)和B组(n=36,术中不结扎脾静脉)。采用SPSS 22.0统计学软件分析数据,围手术期各项指标等计量资料用(±s)表示,采用独立样本t检验;术后并发症等计数资料用χ2检验。P<0.05为差异有统计学意义。

结果

两组患者均完成腹腔镜脾切除术,无中转开腹及死亡病例,B组术后有1例因胰瘘导致出血、经保守治疗后治愈出院。A组手术时间多于B组、术后门静脉血栓形成例数少于B超,差异均有统计学意义(P<0.05);两组患者住院费用、住院时间、术中出血量、术后胰瘘比较,差异均无统计学意义(P>0.05)。

结论

腹腔镜脾切除术中结扎脾静脉近端安全可行,且可有效预防术后门静脉血栓的形成。

Objective

To explore the preventive effect of proximal splenic vein ligation during laparoscopic splenectomy on postoperative portal vein thrombosis.

Methods

The clinical data of 58 patients with portal hypertension who underwent surgical treatment from January 2022 to January 2025 were analyzed retrospectively. According to whether proximal splenic vein ligation was performed during the operation, the patients were divided into Group A (n=22, with intraoperative splenic vein ligation) and Group B (n=36, without intraoperative splenic vein ligation). Statistical software SPSS 22.0 was used for data analysis. Measurement data, such as perioperative indicators, were expressed as (±s) and analyzed by independent samples t test; count data, such as postoperative complications, were analyzed by χ2 test. P<0.05 was considered statistically significant.

Results

All patients in both groups successfully completed laparoscopic splenectomy, with no conversion to open surgery or deaths. In Group B, 1 patient developed bleeding due to pancreatic fistula after surgery and was cured and discharged after conservative treatment. The operation time in Group A was longer than that in Group B, while the number of cases with postoperative portal vein thrombosis in Group A was fewer than that in Group B (Note: There is a typo in the original text; B-ultrasound should be Group B), with statistically significant differences (both P<0.05). There were no statistically significant differences between the two groups in hospitalization costs, length of hospital stay, intraoperative blood loss, or postoperative pancreatic fistula (all P>0.05).

Conclusion

Proximal splenic vein ligation during laparoscopic splenectomy is safe and feasible, and can effectively prevent the formation of postoperative portal vein thrombosis.

表1 两组腹腔镜下脾切除术患者一般资料比较
图2 术后复查增强CT门静脉未见血栓
表2 两组腹腔镜下脾切除术患者手术相关指标比较
[1]
张艳, 诸松, 张剑波. 脾切除术后门静脉系统血栓形成的危险因素及抗凝治疗的最新进展[J]. 临床医学进展, 2025, 15(01): 2280-2285
[2]
Rey Chaves CE, Díaz S, Gómez Garnica D, M. et al. Postoperative outcomes after splenectomy: a 20-year single-center experience in Colombia. BMC Surg, 2024 Nov 16;24(1): 362.
[3]
钟平勇, 王杰, 牟廷刚, 等.预防性抗凝治疗对腹腔镜脾切除联合贲门周围血管离断术后门静脉血栓形成的效果[J]. 中华普通外科杂志, 2020, 35(04) 281-283.
[4]
莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J/CD]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[5]
李虎, 孟令展, 张晓峰, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗门静脉高压症的临床价值评估[J]. 腹腔镜外科杂志, 2024, 29(05): 336-341.
[6]
中华医学会外科学分会脾及门静脉高压外科学组. 腹腔镜贲门周围血管离断术中国专家共识(2022版). 中华消化外科杂志, 2022, 21(06): 701-707.
[7]
Lu X, Zeng W, Zhu L, et al. Application of the Caprini risk assessment model for deep vein thrombosis among patients undergoing laparoscopic surgery for colorectal cancer[J]. Medicine (Baltimore), 2021, 100(4): e24479.
[8]
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2021, 73(1): 366-413.
[9]
耿志达, 俞星新, 刘雨, 梁英健. 脾切除术后门静脉血栓形成及其机制的研究进展[J/CD]. 中华普外科手术学杂志(电子版), 2023, 17(01): 110-113.
[10]
于泽, 罗岩, 陈华, 等. 胰腺术后静脉血栓栓塞的危险因素分析[J]. 中华普通外科杂志, 2025, 40(03): 195-200.
[11]
Wang T, Yong Y, Ge X, et al A computational model-based study on the feasibility of predicting post-splenectomy thrombosis using hemodynamic metrics[J]. Front Bioeng Biotechnol, 2024, 11: 1276999.
[12]
Li Y, Fu X, Li YY, et al. Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization[J]. Surg Endosc, 2022, 36(12): 8918-8926.
[13]
Chun HS, Choe AR, Lee M, et al. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis [J]. Clin Mol Hepatol, 2021, 27(4): 535-552.
[14]
楚慧款, 陈柳莹, 杨玲. 肝硬化门静脉血栓管理面临的困难与挑战[J]. 中华肝脏病杂志, 2021, 29(03): 196-198.
[15]
文雪刚, 毛青松, 龚建平. 肝硬化脾切除术后门静脉血栓形成的预防研究进展[J]. 中国现代普通外科进展, 2023, 26(03): 242-244.
[16]
陈泽平, 朱齐, 朱翔, 等. 脾切除术治疗肝硬化门静脉高压症继发脾功能亢进合并门静脉血栓的效果及安全性[J]. 肝胆胰外科杂志, 2025, 37(01): 5-10.
[17]
McLendon K, Goyal A, Bansal P, et al. Deep Venous Thrombosis Risk Factors [M]. Treasure Island(FL), 2022.
[18]
Lu S, Hu G, Chen S, et al. Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study[J]. Biomed Res Int, 2020, 2020, 9583706.
[19]
田明国, 李宝定, 辛国军, 等. 门静脉高压症脾切除术中脾静脉近端结扎预防门静脉血栓的疗效分析[J]. 中华普通外科杂志, 2021, 36(01): 39-42.
[20]
Broe PJ, Conley CL, Cameron JL. Thrombosis of the portal vein following splenectomy for myeloid metaplasia[J]. Surg Gynecol Obstet, 1981, 152(4): 488-492.
[21]
杨鸿国, 吴伟顶, 胡智明, 等. 脾静脉近端结扎在腹腔镜巨脾切除联合贲门周围血管离断术中的应用[J]. 中华肝胆外科杂志, 2017, 23(12): 849-851.
[22]
Ferrone CR, Konstantinidis IT, Sahani DV, et al. Twenty-three years of the Warshaw operation for distal pancreatectomy with pre-servation of the spleen [J]. Ann Surg, 2011, 253(6): 1136-1139.
[1] 王卫东. 贲门周围血管离断与左膈下静脉的保留[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 464-464.
[2] 叶美妮, 刘思嘉, 臧玉玮, 刘云建. 肝硬化门静脉血栓形成的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 379-384.
[3] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[4] 耿志达, 俞星新, 刘雨, 梁英健. 脾切除术后门静脉血栓形成及其机制的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(01): 110-113.
[5] 罗星玉, 杨喆, 郑树森. 门静脉血栓分型与肝移植门静脉重建策略探讨[J/OL]. 中华移植杂志(电子版), 2023, 17(06): 372-380.
[6] 王飞, 陈政, 余德才, 曹亚娟. 原发性肝癌合并门静脉高压症的微创手术治疗[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 306-310.
[7] 王孟龙. 门静脉高压症肝脏血供改变对肝移植的影响与对策[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 687-692.
[8] 张宏伟, 邢玉雪, 贾哲, 赫嵘, 张珂, 蒋力. 术前输注血小板在肝癌合并肝硬化门静脉高压症肝脾联合切除患者中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 576-581.
[9] 石洋, 郭辉, 李坚. 门静脉高压症TIPS操作规范及其手术相关并发症处理[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 372-378.
[10] 邢颖, 程石. 巨脾外科治疗现状与介入治疗序贯手术策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 253-258.
[11] 张宇, 余灵祥, 赵亮, 张宁, 赵德希, 刁广浩, 杨木易, 刘佳, 李鹏, 任辉. 利伐沙班在脾切除联合贲门周围血管离断术后门静脉血栓预防中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 195-199.
[12] 苏日顺, 卢逸, 庄宝鼎, 张译, 李彦杰, 徐见亮. 肝硬化脾亢脾切除术后门静脉血栓形成影响因素[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 39-44.
[13] 张群青, 吴娟, 王妍. 肝硬化门静脉高压症患者肝脏血流动力学指标与门静脉压力梯度的相关性[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 616-620.
[14] 朱风尚, 舍玲, 丁永年, 杨长青. 五步疑问法在肝硬化门静脉高压症临床教学中的应用[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(02): 116-118.
[15] 吴佳霖, 罗骏阳, 钟胜, 王有枝, 姜在波. 肝内小直径覆膜支架联合抽栓、溶栓治疗门静脉血栓二例[J/OL]. 中华介入放射学电子杂志, 2023, 11(04): 377-379.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?